Medical 3D Printing is one of the growing applications of 3D printing in Asia. From China to Japan, researchers are currently developing innovations that will truly disrupt the area.
Oxford Performance Materials, Inc., a specialist in advanced materials science and high-performance additive manufacturing (HPAM®) announces a collaboration with Tokyo-based materials supplier JSR Corporation (JSR). The collaboration will consist in advancing OPM’s poly-ether-ketone-ketone (PEKK)-based 3D-printed orthopedic devices, biomedical & dental materials businesses throughout Asia.
A key strength in OPM’s OsteoFab surface technology
In general, OsteoFab 3D printing technology attributes are a key enabler in the adoption of OPM’s 3D printed PEKK-based medical implants. Those attributes include desirable economics, biocompatibility, radiolucency as well as bone-like mechanics.
According to researches, OPM’s OsteoFab surface technology integrates antibacterial characteristics inhibiting bacterial attachment, as well as osteoconductive properties that enable a safe growth of bony tissue onto the surface of OsteoFab implants. All of this inevitably results in a better patient recovery and long-term implant fixation.
The agreement between OPM & JSR
As part of this agreement, both companies will establish operations in Japan as OPM Asia, with an exclusive regional license to exploit OPM’s proprietary OsteoFab® biomedical device 3D printing technology and OXPEKK® materials technology.
JSR will be providing the equity capital for OPM Asia that will enable the establishment of a world-class biomedical manufacturing and market development operation. The OPM Asia license will cover a broad territory consisting of Japan, China, Taiwan, Korea, Brunei Darussalam, Cambodia, Lao PDR, Malaysia, Myanmar, Philippines, Singapore, Thailand, Vietnam and India.
“Asia’s healthcare industry is growing rapidly, and with that growth comes increased demand for medical innovation that delivers improved clinical effectiveness to more people with superior economics,” said Scott DeFelice, Chief Executive Officer of Oxford Performance Materials. The healthcare industry in Asia is expected to grow by 11.1% to $517 billion in 2018, representing one of the fastest growing regions in the world, according to Frost & Sullivan. OPM has long identified Asia as an attractive market due to clear demographic trends and a predictable regulatory and reimbursement environment.
JSR has a rapidly growing life sciences business and broad strategic partnerships across Asia. Regarding the OPM Asia partnership, DeFelice stated, “JSR has built an impressive personalized medicine ecosystem, with capabilities in medical 3D software, drug discovery & delivery, and biologics. JSR’s regulatory expertise and partnerships with healthcare providers, including joint development of the JSR-Keio University Medical and Chemical Innovation Center (JKiC), are unique in the region, and JSR will be a strong, influential partner to OPM. We are extremely pleased that JSR has decided to finance the OPM Asia enterprise and work with us to establish the OPM technology platform throughout Japan and the wider region.”
You can now post free of charge job opportunities in the AM Industry on 3D ADEPT Media.
For further information about 3D Printing, follow us on our social networks and subscribe to our newsletter : Facebook, Twitter, LinkedIn & Instagram !
https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js
(adsbygoogle = window.adsbygoogle || []).push({});